Pazdur Calls For 'Kumbaya’ To Standardize ImmunoOncology Biomarkers

 
• By Sarah Karlin-Smith
  
Diverse group of business people coming together in a corporate huddle, stacking their hands together as they stand in an office.
Pazdur said drug sponsors must collaborate on immunology biomarkers moving forward. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from US FDA Performance Tracker

More from Regulatory Trackers